Dingdang Medicine Express, a Chinese online drug retail platform, has secured a RMB600 million (US$89.13 million) series B round of financing, according to a statement released on Thursday. Returning investor Softbank China Venture Capital, and new investors including investment banking firm CMB International Capital, a healthcare-focused fund jointly launched by Sinopharm Group and CICC Capital, […] SoftBank-Backed Chinese Online Drug Retail Platform Dingdang Raises $89M Series B Round comes originally from China Money Network. All Rights Reserved.